MKK4, located in close proximity to p53 gene, is thought to be a tumor suppressor and a metastasis suppressor gene. A low-rate MKK4 gene alteration has been found in a few tumor types, including breast and pancreatic. A suppressor activity for prostate and ovarian tumor metastasis has also been suggested. To understand the pathobiologic roles of MKK4 in tumorigenesis, we examined the phenotypic changes in response to perturbation of the MKK4 expression in breast and pancreatic cancer cell lines. Ectopic expression of MKK4 by adenoviral delivery in MKK4-negative cancer lines stimulated the cell proliferation and invasion, whereas knockdown of MKK4 expression by small interference RNA in an MKK4-positive breast cancer cell line, MDA-MB-231, resulted in decreased anchorage-independent growth, suppressed tumor growth in mouse xenograft model, and increased cell susceptibility to apoptosis brought by stress signals such as serum deprivation. These results argue that MKK4 functions as a prooncogenic molecule instead of a suppressor in breast and pancreatic tumors.
Introduction
MKK4 (also known as JNKK1, MAP2K4, and SEK1) is located on chromosome 17p11.2, closely proximal (approximately 10 cM centromeric) to the p53 tumor suppressor gene. Earlier studies identified alterations of the MKK4 gene in a subset (B3%) of breast, pancreatic, and colorectal cancer cell lines (Teng et al., 1997) as well as xenografts derived from pancreatic and biliary tumors (Su et al., 1998) , whereas screenings of gastric and prostate tumors yielded no such alterations (Kim et al., 2001; Chae et al., 2002) . Identified genetic alterations were somatic which involved either homozygous deletions or intragenic mutations in tumors that were prescreened for positive LOH (Teng et al., 1997; Su et al., 1998 Su et al., , 2002 . MKK4 is thus hypothesized to be a candidate tumor suppressor gene. In addition, MKK4 has been implicated in suppression of tumor metastasis since a microchromosomal region containing the MKK4 gene was found to suppress the tumor cell metastasis (Yoshida et al., 1999) . Decreased immunohistochemical expression of MKK4 has also been observed in prostate and ovarian tumors, and this lowered expression appeared to be associated with more advanced stages of the disease (Kim et al., 2001; Yamada et al., 2002) .
The hypothesis that MKK4 is a tumor suppressor and metastasis suppressor is unusual in light of its central role in the Ras-dependent signaling cascade (Derijard et al., 1995; Lin et al., 1995; Cuenda, 2000) . MKK4 belongs to a network of MAPK pathway, in which MKK4 is positioned upstream of c-JUN NH 2 -terminal kinases (JNK) and p38 (Schaeffer and Weber, 1999; Cuenda, 2000) . Cytokine signals, stress, or other extracellular stimuli activate members of MAP3Ks, such as MEKK1, which in turn lead to phosphorylation and activation of MKK4 (Johnson and Lapadat, 2002) . The activated MKK4 subsequently phosphorylates JNK, p38, and probably other MAPK species on tyrosine and threonine residues (Derijard et al., 1995; Lin et al., 1995) . The activated MAPKs in turn phosphorylate their downstream targets to elicit a variety of biological effects including apoptosis, cell differentiation, and gene transcription. For example, JNK-mediated phosphorylation of c-JUN and possibly other transcription factors is critical for activation of the downstream AP-1-mediated transcriptional events (Davis, 2000) . As a result, one prominent MKK4 function is to mediate stress-activated protein kinase pathway through JNK that has been implicated in apoptosis and neoplastic transformation (Ip and Davis, 1998; Davis, 2000) . MKK4-null mouse is embryonically lethal (Yang et al., 1997; Ganiatsas et al., 1998) , highlighting an indispensable role of MKK4 in development.
To understand the pathobiological functions of MKK4 in the tumorigenic process, we used cell lines of breast and pancreatic cancer, the two tissue types in which MKK4 alterations were most frequently shown (Teng et al., 1997; Su et al., 1998 Su et al., , 2002 . Our results indicated that, instead of the phenotypes expected from a tumor suppressor or a metastasis suppressor, MKK4 exhibited pro-oncogenic activities.
Results

MKK4 expression in breast and pancreatic cancer lines
We used immunoblottings to assess the MKK4 protein expression in a panel of pancreatic (8 lines) and breast (14 lines) cancer cell lines. While cells that reportedly harbored the MKK4 gene homozygous deletion (AsPC1 and DU7745) did not express the MKK4 protein (Figure 1a) , cells that had MKK4 mutations (CaPan1, MDA-MB-134VI, and MDA-MB-415) showed no fulllength MKK4 expression. MKK4 proteins were detectable in the remaining cell lines that showed no alterations (Hs766 T, MiapaCa2, CFPac1, Capan2, SKBr3, T47D, BT474, MCF7, MDA-MB-231, MDA-MB-330, MDAMB-361, MDA-MB-435S, MDA-MB-453, and MDA-MB-468). In addition, immunoblotting identified two cell lines (BxPC3 and HCC1428) that lacked MKK4 expression ( Figure 1a) .
To examine the genetic basis for the lack of MKK4 expression in BxPC3 and HCC1428 cells, we used PCR to amplify the 11 exons (A-K) of the MKK4 gene, using Panc1 (wild-type MKK4) as a positive control (Teng et al., 1997; Su et al., 1998) . Our homozygous deletion screening indicated that BxPC3 and HCC1428 cells had homozygous deletions at the MKK4 locus of exons J-K and F-K, respectively (Figure 1b ). In combination with previous reports (Teng et al., 1997; Su et al., 1998 Su et al., , 2002 , we identified a total of seven breast and pancreatic cell lines with altered MKK4.
MKK4 promotes cell proliferation and invasion
To recapitulate the hypothesized tumor suppression activity of MKK4, we examined the growth of cultured cancer cells in response to ectopic MKK4 expression following adenoviral infection. Cells with tumorigenic MKK4 homozygous deletion provided a natural null background for a clear biological comparison. AsPC1, BxPC3, and DU4475 cells were infected with Ade-MKK4 or a control Ade-LacZ. The DNA synthesis property of the infected cells was then analysed by using [ 3 H]-thymidine incorporation. As shown in Figure 2a , in all the three cell lines examined, MKK4 expression resulted in a significantly higher proliferation rate than the LacZ control (P o 0.05). Thus, the adenovirally delivered overexpression of MKK4 (Figure 2c ) stimulated cell growth.
Ectopically expressed MKK4 also affected the invasion property of cancer cells. Matrigel assays were used to compare invasion potency of the AsPC1 and BxPC3 cells that were infected with Ade-MKK4 or Ade-LacZ. As shown in Figure 2b , in both cell lines overexpression of MKK4 resulted in a marked increase of invasion capacity as compared to LacZ control, indicating that MKK4 promotes cancer cell invasion in vitro.
Growth properties of MKK4-negative cells
The stimulatory responses to ectopically expressed MKK4 were unexpected for a given tumor suppressor gene. The level of MKK4 protein expression achieved by adenoviral infection was significantly above the endogenous level, at which we speculated it might lead to unwanted biochemical reactions. We sought to, therefore, characterize the resultant phenotypic responses by knocking down the endogenous MKK4 expression. An siRNA construct whose transcribed double-stranded RNA product was expected to accelerate MKK4 mRNA Neomycin-resistant clones were tested for MKK4 expression by immunoblottings. Among the 16 stable clones screened, two clones (#5 and #29) showed markedly reduced MKK4 levels, while MKK4 expression in two other clones (#10 and #19) was undetectable ( Figure 3 ). In the remaining 12 clones, MKK4 expression was at levels comparable to those of parental MDA-MB-231 cells (Figure 3 , and data not shown), from which the control lines were selected (see below).
The siRNA targeting was specific for MKK4, since the expression of MKK7, a close MAP2 K family member to MKK4, was not affected (Figure 3) . We also measured the expression level of some other prominent members of the MAPK pathway, including c-JUN, JNK, and p38. No significant difference in p38 and c-JUN expression was found between the MKK4-positive and -negative clones ( Figure 3 ). An overall higher level of JNK expression was, however, found in the MKK4-negative clones, with the exception of clone #1 (MKK4-positive) in which JNK was expressed in a high level (Figure 3 ). This likely reflected the feedback effect of MKK4 on a related pathway member, suggesting a biological link between MKK4 and JNK.
The growth curves of MKK4-negative and MKK4-positive clones were compared. Parental MDA-MB-231 and clones #1, #4, #15, and #30 were randomly chosen as MKK4-positive expressors. The four clones with significantly decreased or absent MKK4 expression (#5, #10, #19, and #29) were used as the MKK4-negative group. Our initial comparison of growth property found no significant difference between the two groups of cells that were cultured in medium supplemented with 10% FBS (13777.12 Â 10 4 and 14075.35 Â 10 4 for four MKK4-negative and five -positive clones, respectively, P ¼ 0.73; Figure 4a , left panel, and Figure 4b ). As MKK4 has been implicated in a pathway responsive to stress signals, we next examined the pattern of their proliferation in a stress environment by serum depriva- When cultured in serum-free medium, it was found that the growth of MKK4-positive cells showed variable but limited dependence on mitogen stimulation. MKK4-negative cells were, however, more sensitive to serum deprivation than their counterparts; after being cultured in serum-free medium for 3 days (day 4), all four MKK4-negative clones (#5, #10, #19, and #29) were unable to survive (Figure 4a , right panel, and Figure 4b ). The average cell number at day 4 for four MKK4-negative clones was 35.374.78 Â 10 4 in comparison with 102714.3 Â 10 4 for five MKK4-positive ones (P ¼ 0.0051). Similar results, albeit less prominent, were found when the medium was replaced with 1% FBS (data not shown).
The poorer survival of MKK4-negative cells was also reflected in their anchorage-independent growth. As shown in Figure 4c , the three MKK4-positive clones examined (7.3371.81) displayed a significantly (P ¼ 0.016) higher rate of clonal outgrowth in soft agar than the four MKK4-negative clones (1.3670.63), suggesting that MKK4 is a pro-survival factor that overcomes the lack of mitogenic stimulation.
In vivo growth properties of MKK4-negative and -positive clones were also compared using a mouse xenograft model. Tumor growth was established by s.c. injection of MKK4-negative (#5, #10, #19, and #29) and MKK4-positive (#1, #4, and #15) clones. At 2 months after the initial injection, the mice were killed for tumor size comparison. As shown in Figure 4d , the average sizes of the tumors collected from all four MKK4-negative clones were smaller than those from the MKK4-positive ones examined. Statistical analyses indicated the difference between the four MKK4-negative clones (31.3711.1 mm 3 ) and the three MKK4-positive clones (294774.0 mm 3 ) was significant (P ¼ 0.0089). Moreover, 46% (11/24) of the planted MKK4-negative clones failed to develop tumors, as compared to 11% (2/18) of the MKK4-positive cells. These results suggested that suppression of MKK4 expression inhibited tumor growth in vivo.
Serum starvation-induced apoptosis of MKK4-negative cells
The marked decrease of cell number after 3 days of serum starvation of MKK4-negative cells led us to look for a possible apoptotic mechanism. Flow cytometrybased TUNEL assays were used to measure the percentage of the apoptotic population. MKK4-positive and -negative cells were cultured in serum-free media for 3 days prior to TUNEL assays. The average percentage of TUNEL-labeled cells for four MKK4-negative clones was 7.1772.04%. This was in comparison to 1.8870.39% for five MKK4-positive clones. Statistical analyses showed that this difference was significant (P ¼ 0.02, Figure 5a ). These results suggested that cells with downregulated MKK4 expression were prone to cell death induced by stress signals such as serum starvation.
Apoptotic events are associated with a series of cleavages and activation of caspases, among which caspase-3 is the most prominent effector caspase (Cryns and Yuan, 1998) . To further verify the apoptotic mechanism following serum starvation, we compared the level of cleaved and active caspase-3 proteins in the MKK4-negative and MKK4-positive clones that were induced by serum starvation. When cultured in fullserum medium, no cleaved caspase-3 immunoreactive species were found in either group (data not shown). However, following 3 days of serum starvation, cells lacking MKK4 contained a higher level of cleaved caspase-3 than did MKK4-positive cells (Figure 5b) , suggesting that caspase-3 activation plays a role in the higher apoptotic incidence in the MKK4-negative cells. Activated caspase-3 catalyses the specific cleavage of some key apoptosis-associated proteins including PARP (Lazebnik et al., 1994) . Consistent with elevated caspase-3 activation, MKK4-negative clones displayed higher levels of PARP cleavage than their MKK4-positive counterparts (Figure 5b ). Together, these results indicated that, following serum starvation, activation of the cellular apoptotic machinery contributed to the death of cells lacking MKK4.
Discussion
In the present study, we analysed phenotypic changes in response to perturbation of the MKK4 expression Our results showed the pro-oncogenic activity of MKK4 in the breast and pancreatic cancer cell lines examined, as evident from growth and invasion stimulation by ectopic MKK4 expression and susceptibility to stressinduced apoptosis by MKK4 knockdown. These results contrast with the current paradigm the MKK4 gene as a tumor suppressor or a metastasis suppressor.
The tumor suppressor gene was implicated by a lowrate (o3%) of intragenic alterations of MKK4 in tumor cell lines, including those originating in breast, pancreas, lung, and colon (Teng et al., 1997; Su et al., 1998 Su et al., , 2002 . Similar rate of alterations was found in pancreatic and biliary tumors by comparing paired tumor xenografts and germline DNA (Su et al., 1998) , but not in such other types as gastric (Chae et al., 2002) and prostate (Kim et al., 2001) tumors. According to Knudson's twohit hypothesis (Knudson, 1971) , these tumorigenic mutations are assumed to take out MKK4 tumor suppressor activity by biallelic inactivation (loss-offunction), although the true biological effect of these mutations remains uncharacterized. The locus of the MKK4 gene on 17p is in close proximity to that of the p53 gene. Speculation is that the LOH that targets p53 may be responsible for some, if not all, of the 'extended' allelic loss at the MKK4 locus. Future functional studies of tumorigenic MKK4 mutants are needed to determine whether they represent 'loss-of-function' variations or dominant traits.
While the relationship of MKK4 to the tumorigenic process remains elusive, recent studies suggested that MKK4 had a role in suppressing prostate and ovarian cancer metastasis. It was shown that MKK4 did not affect the proliferation of prostate and ovarian cancer cells, but MKK4 overexpressors were found to exhibit decreased metastasis in a mouse experimental metastasis model (Kim et al., 2001; Yamada et al., 2002) . The loss of MKK4 expression in tumors was hypothesized to result in resistance to apoptosis induced by extracellular stress signals, thus enhancing metastatic colonization. In contrast, our study showed that lack of MKK4 resulted in a cellular susceptibility to stress-induced apoptosis and suppressed in vivo growth (Figures 4 and 5) . Moreover, MKK4 overexpression directly stimulated proliferation and invasion of breast and pancreatic cancer cells (Figure 2 ). Additional complexity lies in the clinical significance of differential MKK4 expression in tumors vs normal epithelial cells. Histological loss of MKK4 expression was found correlated with poor pathological grading of both prostate and ovarian cancers (Kim et al., 2001; Yamada et al., 2002) . Clinical correlation studies of MKK4 expression at other sites, however, pointed to a contrasting view; in gastric cancer, for example, a higher MKK4 expression was shown to be an adverse prognostic marker inversely associated with the overall and relapse-free survivals (Wu et al., 2000) . The inconsistent findings of these studies call attention to the complex nature of the MKK4 biology, whose signaling may well be contextdependent and probably vary significantly in tumors at different sites. How the MKK4 expression level as well as genetic alteration is correlated with clinical representations of other tumor types, including breast and pancreas, should provide insight to reconciling these differences.
The conflicting biological responses of MKK4 in human malignancy may in fact reflect the complexity of MAPK signal transduction. JNK, the most consistent MKK4 downstream molecule, is known for its roles in mediation of cytokine and stress signals, and probably in tumor development (Ip and Davis, 1998; Schaeffer and Weber, 1999; Cuenda, 2000; Davis, 2000) . But observations of the roles of JNK in cell survival and proliferation have been somewhat contradictory. A large body of evidence showed that activation of JNK acted as a survival signal, and that phosphorylation of c-JUN by JNK was required for transformation induced by oncogenes such as Ras (Behrens et al., 2000; Davis, 2000; Xiao and Lang, 2000) . While JNK was shown to be required for tumor growth (Yang et al., 2003) , inhibition of JNK expression reduced oncogenic transformation in cell lines of various tissue origins Potapova et al., 1997 Potapova et al., , 2000 . Furthermore, using a mouse knockout model JNK was shown to be required to promote survival of Blymphoblasts transformed by Bcr-Abl (Hess et al., 2002) . The pro-survival response mediated by JNK is reminiscent of MKK4À/À mice in which increased apoptosis of thymocytes (Nishina et al., 1997) and hepatocytes (Ganiatsas et al., 1998) was identified, likely due to the defective JNK phosphorylation in the absence of MKK4 (Yang et al., 1997; Ganiatsas et al., 1998) . In contrast, JNK appears to be a suppressor protein in some experimental models. For example, JNK-null fibroblasts transformed by Ras were found to have a higher proliferation rate in nude mice than the wild-type cells (Kennedy et al., 2003) . Whether this effect represents a true JNK in vivo effect or a phenomenon uniquely occurred in Ras-transformed fibroblasts remains to be tested. Interestingly, the in vitro growth of the same Ras-transformed fibroblasts in soft agar was found to be stimulated by JNK, reflecting the complexity of the MAPK pathway that integrates multiple signals in a tissue-specific manner. The biological activity of MKK4 in tumors has not been systematically examined. Our present in vitro and in vivo data using breast and pancreatic cancer cell lines are in agreement with the pro-oncogenic activities of MKK4 that may also be prevalent in other tumor types (Lee et al., 2003) . 
Materials and methods
Recombinant adenovirus
A commercial kit (Adeno-X; from Clontech) was used to prepare the recombinant adenovirus encoding the human MKK4 cDNA. The MKK4 cDNA (Derijard et al., 1995) was amplified by PCR from pCMV-FLAG-MKK4b (a gift from Dr Roger Davis, University of Massachusetts). The PCR products were subcloned into pShuttle (Clontech). The integrity of the MKK4 reading frame was verified by automated sequencing. Then the MKK4 cDNA was released from pShuttle by PI-SceI and I-ceuI restriction digestions, and the released fragment was inserted into predigested Adeno-X viral DNA vector. The DNA was transfected into HEK293 cells by Fugene6 (Roche). Adenovirus was amplified by series of lysing and re-infection of HEK293 cells. The LacZ control virus was similarly prepared. The viral titers measured in plaque-forming units/ml were quantified by end-point dilution assays. 
Cell proliferation, invasion, and colony formation assays
Thymidine incorporation assays were used to measure the DNA synthesis rate as previously described (Dai et al., 1999b) . AsPC1, BxPC3, and DU4475 cells were infected with Ade-MKK4 or Ade-LacZ at MOI of 40 : 1. No cell toxicity was observed under this condition by comparing the proliferation rate and the invasion capacity of Ade-LacZ-infected and noninfected cells. Following 3 days of infection, cells were pulsed with [
3 H]-thymidine (NEN). Following 2-to 4-h labeling, acid -soluble tritium was removed by trichloroacetic acid washes. The acid-insoluble components that represented the relative cell proliferation rate were determined by scintillation counting (MicroBeta Trilux 1450, Perkin-Elmer -Wallac). The change of proliferation rate was obtained by dividing the counts in the presence of MKK4 by the ones in LacZ control.
Serum dependence was determined by seeding individual clones (2 Â 10 5 cells per dish) onto 35-mm plates and incubating at 371C in DMEM-F12 media supplemented with 10% FBS. After overnight incubation, culture medium was replaced with serum-free DMEM-F12, and viable cells were counted at sequential intervals to establish the growth curve.
Matrigel assays were carried out essentially as described previously (Wang et al., 2003) . Briefly, cells that were infected with Ade-MKK4 or Ade-Lac. Following 2 days of infection, 1 Â 10 5 cells were plated on each matrigel-coated transwell. After an overnight incubation, cells that penetrated through the matrigel were stained and counted.
To analyse anchorage-independent growth, 1 Â 10 5 cells were seeded in 60-mm dishes with a 1.5-ml top layer of 0.35% (w/v) low-melting agarose, which was overlaid onto 4 ml of 0.7% (w/v) agarose. Both layers contained 1 Â culture media and 10% FBS. Cells were chilled at 41C for 15 min before transfer to 371C CO 2 incubator. At 1 month after plating, the formed colonies were stained with p-iodonitrotetrazolium violet (0.4 mg/ml); 20 random fields were counted and the average plotted.
Measurement of in vivo tumor growth
MKK4-negative and -positive clone s.c. xenografts were initiated by injecting 2 Â 10 6 cells re-suspended in 200 ml PBS into the left and right flanks of SCID mice (Harlan Sprague Dawley). Tumor size was monitored weekly. At 2 months after the initial injection, mice were sacrificed and the final tumor volume was calculated as previously described (Rockwell et al., 1972) . All animal procedures were performed following the recommendations of the Institutional Animal Care and Use Committee.
Homozygous deletion analyses
The DNeasy kit (Qiagen) was used to extract genomic DNA from cultured cells. PCR amplification of genomic DNA was used to analyse homozygous deletion of the MKK4 gene. Individual exons (exons A-K) were amplified by PCR, using primers corresponding to the neighboring intronic sequences. The primers used to amplify the MKK4 exons were the same as described previously (Teng et al., 1997) 
Inhibition of MKK4 expression by siRNA
A vector-based siRNA method (Sui et al., 2002) was used to generate clones that had inhibited MKK4 expression. The twostep ligation was used to insert the interfering sequences into pBS/U6 (a gift from Dr. Yang Shi, Harvard Medical School), yielding pBS/U6-MKK4. Oligo sequences were 5'-GGATTT-CACTGCAGAGGACTTA-3' (oligo 1, forward), 5'-AGCT-TAAGTCCTCTGCAGTGAAATCC-3' (oligo 1, reverse), 5'-AGCTTAAGTCCTCTGCAGTGAAATCCCTTTTTG-3' (oligo 2, forward), and 5'-AATTCAAAAAGGGATTT-CACTGCAGAGGACTTA-3' (oligo 2, reverse). The targeting sequences in pBS/U6-MKK4 were verified by automated sequencing.
An MKK4-positive breast cancer line, MDA-MB-231, was transfected with pBS/U6-MKK4. pcDNA3.1( þ ) (Invitrogen) was co-transfected to provide the neomycin selection marker. Cell transfectants were subjected to G418 selection (600 mg/ml, active concentration; Invitrogen) by limited dilution in 96-well plates. Individual G418-resistant clones were expanded in culture and screened for MKK4 expression by immunoblottings.
Immunoblottings
Immunoblotting analyses were carried out essentially as described previously (Wang et al., 2003) . Antibodies for immunoblotting were purchased from either Santa Cruz Biotechnologies [MKK4 (K-18), b-actin (I-19)] or Cell Signaling [MKK7 (#4172), JNK (#9252), c-Jun (#9162), Caspase-3 (8G10), p38 (#9212), and PARP (#9542)].
TUNEL analyses
An Apo-kit (BD Biosciences PharMingen) was used for the TUNEL assays to quantify the percentage of cells undergoing apoptosis (Dai et al., 1999a) . Stable clones were plated on 60-mm plates at 1 Â 10 6 cells per dish. After serum deprivation for 3 days, floating cells were first collected. The attached cells were then harvested by trypsinization. Cells were then pooled and fixed by paraformaldehyde and permeabilized with 70% ethanol. Fragmented DNA ends as present in apoptotic cells were labeled with dUTP-FITC in a reaction containing terminal deoxynucleotide transferase. Cells were then stained with PI solution that contained RNase A. Both PI and FITC signals were measured by flow cytometry. FITC signals were acquired on a log scale and PI on a linear scale; 10 000-20 000 events were analysed. A trapezoidal window was selected to separate the labeled apoptotic and nonlabeled cells. A baseline population of apoptotic cells (o0.5%) was negligible in serumfed cells in comparison to the ones in serum-starved cells (5-20%).
Statistical analyses
Differences between experimental and control values were evaluated by Student's t-test.
Abbreviations JNK, c-JUN NH 2 -terminal kinase; LOH, loss of heterozygosity; MAPK, mitogen-activated protein kinase; MKK4, mitogen-activated protein kinase kinase 4; MKK7, mitogenactivated protein kinase kinase 7; MOI, multiplicity of infection; PBS, phosphate-buffered saline; PARP, poly(ADPribose) polymerase; PCR, polymerase chain reaction; PI, propidium iodine; RT-PCR, reverse transcriptase-PCR; siRNA, small interference RNA; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling.
